Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro
Authors:
- Klaus EleniusKEKlaus Elenius
- Reidar GrénmanRGReidar Grénman
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 92 (3) , 388-392
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: Differential response of cancer stem cells and nontumourigenic cells?Radiotherapy and Oncology, 2007
- EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanismsRadiotherapy and Oncology, 2007
- Is there a new role for induction chemotherapy in the treatment of head and neck cancer?JNCI: Journal of the National Cancer Institute, 2004
- The epidermal growth factor receptor mediates radioresistanceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neckRadiation Oncology Investigations, 1997
- Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinomaBritish Journal of Cancer, 1996
- The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivitiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.Journal of Clinical Oncology, 1993
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991
- Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomasHead & Neck, 1991